BIOMODEX® part of Mentice

BIOMODEX® is a medical technology company that specializes in biorealistic 3D printing and flow systems for patient-specific rehearsal and advanced physician training in interventional procedures. The company, originally based in Boston and Paris, is now part of Mentice AB, a leader in simulation solutions for image-guided interventional therapies. The core offering of BIOMODEX is an enhanced 3D printing platform that creates patient-specific anatomical models from imaging data, such as CTA or 3D rotational angiography, within five working days. These models replicate the mechanical behavior of human tissues and simulate realistic fluid dynamics, allowing physicians to rehearse complex procedures in a hands-on environment. This approach improves procedural planning and training outside the cath lab. BIOMODEX's products are designed for training and rehearsal purposes, catering to interventional physicians and surgeons who seek patient-specific simulation tools to enhance their skills and optimize treatment strategies. As part of Mentice, BIOMODEX contributes to a comprehensive ecosystem of simulation solutions focused on improving patient safety and clinical outcomes.

• Employees 3
• Founded 2015
• Total Funding $15089689